Cargando…
A strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases
Background: Chronic liver diseases (CLD) frequently derive from hepatic steatosis, inflammation and fibrosis, and become a leading inducement of cirrhosis and hepatocarcinoma. Molecular hydrogen (H(2)) is an emerging wide-spectrum anti-inflammatory molecule which is able to improve hepatic inflammat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196827/ https://www.ncbi.nlm.nih.gov/pubmed/37215568 http://dx.doi.org/10.7150/thno.80494 |
_version_ | 1785044427931123712 |
---|---|
author | Tao, Geru Liu, Feng Jin, Zhaokui Liu, Boyan Wang, Hao Li, Daosheng Tang, Wei Chen, Yuan He, Qianjun Qin, Shucun |
author_facet | Tao, Geru Liu, Feng Jin, Zhaokui Liu, Boyan Wang, Hao Li, Daosheng Tang, Wei Chen, Yuan He, Qianjun Qin, Shucun |
author_sort | Tao, Geru |
collection | PubMed |
description | Background: Chronic liver diseases (CLD) frequently derive from hepatic steatosis, inflammation and fibrosis, and become a leading inducement of cirrhosis and hepatocarcinoma. Molecular hydrogen (H(2)) is an emerging wide-spectrum anti-inflammatory molecule which is able to improve hepatic inflammation and metabolic dysfunction, and holds obvious advantages in biosafety over traditional anti-CLD drugs, but existing H(2) administration routes cannot realize the liver-targeted high-dose delivery of H(2), severely limiting its anti-CLD efficacy. Method: In this work, a concept of local hydrogen capture and catalytic hydroxyl radical (·OH) hydrogenation is proposed for CLD treatment. The mild and moderate non-alcoholic steatohepatitis (NASH) model mice were intravenously injected with PdH nanoparticles firstly, and then daily inhaled 4% hydrogen gas for 3 h throughout the whole treatment period. After the end of treatment, glutathione (GSH) was intramuscularly injected every day to assist the Pd excretion. Results: In vitro and in vivo proof-of-concept experiments have confirmed that Pd nanoparticles can accumulate in liver in a targeted manner post intravenous injection, and play a dual role of hydrogen captor and ·OH filter to locally capture/store the liver-passing H(2) during daily hydrogen gas inhalation and rapidly catalyze the ·OH hydrogenation into H(2)O. The proposed therapy significantly improves the outcomes of hydrogen therapy in the prevention and treatment of NASH by exhibiting a wide range of bioactivity including the regulation of lipid metabolism and anti-inflammation. Pd can be mostly eliminated after the end of treatment under the assistance of GSH. Conclusion: Our study verified a catalytic strategy of combining PdH nanoparticles and hydrogen inhalation, which exhibited enhanced anti-inflammatory effect for CLD treatment. The proposed catalytic strategy will open a new window to realize safe and efficient CLD treatment. |
format | Online Article Text |
id | pubmed-10196827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-101968272023-05-20 A strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases Tao, Geru Liu, Feng Jin, Zhaokui Liu, Boyan Wang, Hao Li, Daosheng Tang, Wei Chen, Yuan He, Qianjun Qin, Shucun Theranostics Research Paper Background: Chronic liver diseases (CLD) frequently derive from hepatic steatosis, inflammation and fibrosis, and become a leading inducement of cirrhosis and hepatocarcinoma. Molecular hydrogen (H(2)) is an emerging wide-spectrum anti-inflammatory molecule which is able to improve hepatic inflammation and metabolic dysfunction, and holds obvious advantages in biosafety over traditional anti-CLD drugs, but existing H(2) administration routes cannot realize the liver-targeted high-dose delivery of H(2), severely limiting its anti-CLD efficacy. Method: In this work, a concept of local hydrogen capture and catalytic hydroxyl radical (·OH) hydrogenation is proposed for CLD treatment. The mild and moderate non-alcoholic steatohepatitis (NASH) model mice were intravenously injected with PdH nanoparticles firstly, and then daily inhaled 4% hydrogen gas for 3 h throughout the whole treatment period. After the end of treatment, glutathione (GSH) was intramuscularly injected every day to assist the Pd excretion. Results: In vitro and in vivo proof-of-concept experiments have confirmed that Pd nanoparticles can accumulate in liver in a targeted manner post intravenous injection, and play a dual role of hydrogen captor and ·OH filter to locally capture/store the liver-passing H(2) during daily hydrogen gas inhalation and rapidly catalyze the ·OH hydrogenation into H(2)O. The proposed therapy significantly improves the outcomes of hydrogen therapy in the prevention and treatment of NASH by exhibiting a wide range of bioactivity including the regulation of lipid metabolism and anti-inflammation. Pd can be mostly eliminated after the end of treatment under the assistance of GSH. Conclusion: Our study verified a catalytic strategy of combining PdH nanoparticles and hydrogen inhalation, which exhibited enhanced anti-inflammatory effect for CLD treatment. The proposed catalytic strategy will open a new window to realize safe and efficient CLD treatment. Ivyspring International Publisher 2023-04-23 /pmc/articles/PMC10196827/ /pubmed/37215568 http://dx.doi.org/10.7150/thno.80494 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Tao, Geru Liu, Feng Jin, Zhaokui Liu, Boyan Wang, Hao Li, Daosheng Tang, Wei Chen, Yuan He, Qianjun Qin, Shucun A strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases |
title | A strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases |
title_full | A strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases |
title_fullStr | A strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases |
title_full_unstemmed | A strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases |
title_short | A strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases |
title_sort | strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196827/ https://www.ncbi.nlm.nih.gov/pubmed/37215568 http://dx.doi.org/10.7150/thno.80494 |
work_keys_str_mv | AT taogeru astrategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT liufeng astrategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT jinzhaokui astrategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT liuboyan astrategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT wanghao astrategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT lidaosheng astrategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT tangwei astrategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT chenyuan astrategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT heqianjun astrategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT qinshucun astrategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT taogeru strategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT liufeng strategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT jinzhaokui strategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT liuboyan strategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT wanghao strategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT lidaosheng strategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT tangwei strategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT chenyuan strategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT heqianjun strategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases AT qinshucun strategyoflocalhydrogencaptureandcatalytichydrogenationforenhancedtherapyofchronicliverdiseases |